Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
0.8789
+0.0263 (3.08%)
At close: Nov 14, 2025, 4:00 PM EST
0.8926
+0.0137 (1.56%)
After-hours: Nov 14, 2025, 4:04 PM EST
Trinity Biotech Market Cap
Trinity Biotech has a market cap or net worth of $16.32 million as of November 14, 2025. Its market cap has decreased by -14.66% in one year.
Market Cap
16.32M
Enterprise Value
111.70M
1-Year Change
-14.66%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since October 9, 1997, Trinity Biotech's market cap has decreased from $44.82M to $16.32M, a decrease of -63.59%. That is a compound annual growth rate of -3.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 15.83M | 3.20% |
| Dec 31, 2024 | 15.34M | -6.42% |
| Dec 29, 2023 | 16.39M | -56.55% |
| Dec 30, 2022 | 37.73M | 26.22% |
| Dec 31, 2021 | 29.89M | -62.47% |
| Dec 31, 2020 | 79.64M | 268.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 915.86B |
| Johnson & Johnson | 470.41B |
| AbbVie | 410.55B |
| UnitedHealth Group | 301.21B |
| AstraZeneca | 276.17B |
| Novartis AG | 256.16B |
| Merck & Co. | 230.65B |
| Abbott Laboratories | 224.77B |